May 10

Advances in Autism Research and Treatment: Insights From the Israeli Desert

Palo Alto, California

This event has passed.
Advances in Autism Research and Treatment: Insights From the Israeli Desert
Dr. Ilan Dinstein
BGU's Department of Psychology, Zlotowski Center for Neuroscience
Dr. Gal Meiri
Child Psychiatrist, Head of Preschool Psychiatric Unit, Soroka University Medical Center Faculty Member, BGU's Faculty of Health Sciences
Dr. Idan Menashe
Department of Public Health, Zlotowski Center for Neuroscience, BGU's Faculty of Health Sciences 
This event has passed.
Wednesday, May 10, 2017

7:30 p.m.
Oshman Family JCC
3921 Fabian Way
Palo Alto, California

Learn about the cutting-edge science and therapeutic approaches being developed at the Negev Autism Research Center


R.S.V.P. required to 415-927-2119 or


Free admission  •  Space is limited

There will be no solicitation of funds at this event.

Dr. Ilan Dinstein, Ph.D., a faculty member of BGU’s Department of
Psychology and the Zlotowski Center for Neuroscience since 2012,
established Israel’s first neurophysiological autism lab. Dr. Dinstein
and his research team use neuroimaging techniques, such as MRI and
EEG, to study brain structure and function in children with autism.
Their goal is to identify objective biological measures for diagnosis
at earlier ages and for distinguishing between different sub-types of
autism, which will enable clinicians to use earlier targeted

Dr. Dinstein earned his Ph.D. in neuroscience at New York University
and did postdoctoral work at the Weizmann Institute and Carnegie
Mellon University. In recognition of his achievements, he was awarded
an Alon Fellowship from the Israeli Council for Higher Education, the
Sieratzki Prize for Advances in Neuroscience, and the Toronto award
for excellence in research.

Dr. Gal Meiri, M.D. is a child psychiatrist and head of the
Preschool Psychiatric Unit at Soroka University Medical Center, the
teaching hospital for BGU’s Faculty of Health Sciences. Dr. Meiri and
his clinical team diagnose and treat a variety of problems and
disorders in infants and toddlers from throughout the Negev,
approximately one quarter of whom are diagnosed with autism spectrum
disorder (ASD). Dr. Meiri is particularly committed to improving
autism awareness in the Bedouin community, where it was largely
undiagnosed prior to his efforts over the past decade.

Dr. Meiri earned his M.D. and M.H.A. degrees at BGU, and he did part
of his residency and a research fellowship at the Oregon Health
Sciences University in Portland, Oregon. He was recently the president
of the Israeli Association of Infant Mental Health and is an active
member of the National Committee of Experts on Autism in the Israeli
Ministry of Health.

Dr. Idan Menashe, Ph.D. is a senior lecturer in BGU’s
Department of Public Health in the Faculty of Health Sciences, with a
particular research focus on the genetic epidemiology of autism
spectrum disorder (ASD). Dr. Menashe applies state-of-the-art
bioinformatics and biostatistics approaches to studying large medical
datasets to determine the contributions of both genetic and
environmental risk factors for developing ASD. He and his team also
study the genetic mechanism in children with autism who possess
exceptional talents, known as savant syndrome.

Dr. Menashe earned his Ph.D. in Molecular Genetics and Bioinformatics
from the Weizmann Institute, and did postdoctoral work at the National
Cancer Institute in Bethesda, Maryland. He also served as a
bioinformatics scientist for neurodevelopmental disorders at MindSpec
in Virginia.